Resolution of oral ulcerations after decreasing the dosage of tacrolimus in a liver transplantation recipient

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics

Volumn 92, Issue 5, 2001, Pages 526-531

  Vallejo Hernández, Gonzalo ^a   Jiménez, Carlos ^b   Arriba, Lorenzo ^a   Moreno, Enrique ^b   Lucas, Miguel ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

ALCOHOL LIVER CIRRHOSIS; ARTICLE; BLOOD; CASE REPORT; CHEMICALLY INDUCED DISORDER; DYSPHAGIA; FOLLOW UP; HUMAN; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MOUTH ULCER; ORAL DRUG ADMINISTRATION; RECURRENT DISEASE; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; DEGLUTITION DISORDERS; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER CIRRHOSIS, ALCOHOLIC; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; ORAL ULCER; RECURRENCE; RETROSPECTIVE STUDIES; TACROLIMUS; TREATMENT OUTCOME;

EID: 0035515464     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1067/moe.2001.116152     Document Type: Article

References (43)

1. Somacarrera ML, Hernández G, Acero J, Moskow BS. Factors related to the incidence and severity of cyclosporin-induced gingival overgrowth in transplant patients. A longitudinal study. J Periodontol 1994;65:671-5.
2. Qunibi WY, Akhtar M, Ginn E, Smith P. Kaposi's sarcoma in cyclosporine-induced gingival hyperplasia. Am J Kidney Dis 1988;11:349-52.
3. King GN, Healy CH, Glover MT, Kwan JT, Williams DM, Leigh IM, et al. Prevalence and risk factors associated with leukoplakia, hairy leukoplakia, erythematous candidiasis, and gingival hyperplasia in renal transplant recipients. Oral Surg Oral Med Oral Pathol 1994;78:718-26.
4. Seymour RA, Thomason JM, Nolan A. Oral lesions in organ transplant patients. J Oral Pathol Med 1997;26:297-304.
5. Rubin RH. Infection in the renal and liver transplant patient. In: Rubin RH, Young LS, editors. Clinical approach to infection in the compromised host. 2nd ed. New York: Plenum Medical Book Co; 1988. p. 557-621.
6. Kino T, Hatanaka H, Hashimoto M, Nishiyama M, Goto T, Okuhara M, et al. FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physicochemical and biological characteristics. J Antibiot (Tokyo) 1987;40:1249-55.
7. Busuttil RW, Holt CD. Tacrolimus is superior to cyclosporine in liver transplantation. Transplant Proc 1998;30:2174-8.
8. Laskow DA, Neylan JF, Shapiro RS, Pirsch JD, Vergne-Marini PJ, Tomlanovich SJ. The role of tacrolimus in adult kidney transplantation: a review. Clin Transplant 1998;12:489-503.
9. Hernández G, Arriba L, Lucas M, de Andrés A. Reduction of severe gingival overgrowth in a kidney transplant patient by replacing cyclosporin A with Tacrolimus. J Periodontol 2000; 71:1630-6.
10. Mihatsch MJ, Kyo M, Morozumi K, Yamaguchi Y, Nickeleit V, Ryffel B. The side effects of cyclosporine-A and tacrolimus. Clin Nephrol 1998;49:356-63.
11. Cawson RA, Odell EW. Essentials of oral pathology and oral medicine. Edinburgh: Churchill Livingstone; 1998. p. 183-6.
12. Reyes-Terán G, Ramírez-Amador V, de la Rosa E, González-Guevara M, Ponce de León S. Major recurrent oral ulcers in AIDS: report of three cases. J Oral Pathol Med 1992;21:409-11.
13. Ficarra G. Oral ulcerations in patients with HIV infection: etiology, diagnosis and management. In: Greenspan JS, Greenspan D, editors. Proceedings of the II International Workshop on Oral Manifestations of HIV infection. Chicago: Quintessence Publishing; 1995. p. 205-17.
14. Glick M, Garfunkel AA. Common oral findings in two different diseases: leukemia and AIDS: Part 1. Compendium 1992;13: 432, 434, 436.
15. Garfunkel AA, Glick M. Common oral findings in two different diseases: leukemia and AIDS: Part 2. Compendium 1992;13: 550, 552-3, 556.
16. Reichart PA. Oral ulceration and iatrogenic disease in HIV infection. Oral Surg Oral Med Oral Pathol 1992;73:212-4.
17. Reichart PA. Oral ulceration in HIV infection. Oral Dis 1997; 3:180-2.
18. Syrjänen S, Leimola-Virtanen R, Schmidt-Westhausen A, Reichart PA. Oral ulcers in AIDS patients frequently associated with cytomegalovirus (CMV) and Epstein-Barr virus (EBV) infections. J Oral Pathol Med 1999;28:204-9.
19. Rand KH, Rasmussen LE, Pollard RB, Arvin A, Merigan TC. Cellular immunity and herpesvirus infections in cardiac transplant patients. N Engl J Med 1977;296:1372-7.
20. Pass RF, Whitley RJ, Whelchel JD, Diethelm AG, Reynolds DW, Alford CA. Identification of patients with increased risk of infection with herpes simplex virus after renal transplantation. J Infect Dis 1979;140:487-92.
21. Greenberg MS, Friedman H, Cohen SG, Oh SH, Laster L, Starr S. A comparative study of herpes simplex infections in renal transplant and leukemic patients. J Infect Dis 1987;156:280-7.
22. MacPhail LA, Greenspan D, Greenspan JS. Recurrent aphthous ulcers in association with HIV infection. Diagnosis and treatment. Oral Surg Oral Med Oral Pathol 1992;73:283-8.
23. Bach MC, Valenti AJ, Howell DA, Smith TJ. Odynophagia from aphthous ulcers of the pharynx and esophagus in the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1988; 109:338-9.
24. Muzyka BC, Glick M. Major aphthous ulcers in patients with HIV disease. Oral Surg Oral Med Oral Pathol 1994;77:116-20.
25. Piluso S, Ficarra G, Lucatorto FM, Orsi A, Dionisio D, Stendardi L, et al. Cause of oral ulcers in HIV-infected patients: a study of 19 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996;82:166-72.
26. Phelan JA, Eisig S, Freedman PD, Newsome N, Klein RS. Major aphthous-like ulcers in patients with AIDS. Oral Surg Oral Med Oral Pathol 1991;71:68-72.
27. Classification and diagnostic criteria for oral lesions in HIV infection. EC-Clearinghouse on oral problems related to HIV infection and WHO Collaborating Centre on Oral Manifestations of the Immunodeficiency Virus. J Oral Pathol Med 1993;22:289-91.
28. Rubin RH. Impact of cytomegalovirus infection on organ transplant recipients. Rev Infect Dis 1990;12:S754-66.
29. Schubert MM, Epstein JB, Lloid ME, Cooney E. Oral infections due to Cytomegalovirus in immunocompromised patients. J Oral Pathol Med 1993;22:268-73.
30. Woo SB, Lee SF. Oral recrudescent herpes simplex virus infection. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997;83:239-43.
31. Siegel MA, Balciunas BA. Medication can induce severe ulcerations. J Am Dent Assoc 1991;122:75-7.
32. Shotts RH, Scully C, Avery CM, Porter SR. Nicorandil-induced severe oral ulceration: a newly recognized drug reaction. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;87:706-7.
33. Cohen DM, Bhattacharyya I, Lydiatt WM. Recalcitrant oral ulcers caused by calcium channel blockers: diagnosis and treatment considerations. J Am Dent Assoc 1999;130:1611-8.
34. Gilquin J, Weiss L, Kazatchkine MD. Genital and oral erosions induced by foscarnet. Lancet 1990;335:287.
35. Penneys NS, Hicks B. Unusual cutaneous lesions associated with acquired immunodeficiency syndrome. J Am Acad Dermatol 1985;13:845-52.
36. McNeely MC, Yarchoan R, Broder S, Lawley TJ. Dermatologic complications associated with administration of 2′, 3′-dideoxycytidine in patients with human immunodeficiency virus infection. J Am Acad Dermatol 1989;21:1213-7.
37. Vincent SD, Lilly GE. Clinical, historic, and therapeutic features of aphthous stomatitis. Literature review and open clinical trial employing steroids. Oral Surg Oral Med Oral Pathol 1992;74: 79-86.
38. de Wazieres B, Gil H, Magy N, Berthier S, Vuitton DA, Dupond JL. Treatment of recurrent ulceration with low doses of thalidomide. Pilot study in 17 patients. Rev Med Interne 1999;20:567-70.
39. Kershner RP, Fitzsimmons WE. Relationship of FK506 whole blood concentrations and efficacy and toxicity after liver and kidney transplantation. Transplantation 1996;62:920-6.
40. Robinson BV, Boyle GJ, Miller SA, Law YM, Myers JL, Griffith BP, et al. Optimal dosing of intravenous tacrolimus following pediatric heart transplantation. J Heart Lung Transplant 1999; 18:786-91.
41. Williams R, Neuhaus P, Bismuth H, McMaster P, Pichlmayr R, Calne R, et al. Two-year data from the European multicentre tacrolimus (FK506) liver study. Transpl Int 1996;9:S144-50.
42. Spencer CM, Goa KL, Gillis JC. Tacrolimus. An update of its pharmacology and clinical efficacy in the management of organ transplantation. Drugs 1997;54:925-75.
43. Wiesner RH. A long-term comparison of tacrolimus (FK506) versus cyclosporine in liver transplantation: a report of the United States FK506 Study Group. Transplantation 1998;66:493-9.